Published On : September 2026
A deal team assuming sector label alone predicts growth buyout appeal is overlooking the variable that actually shapes sector preference first.
Within the European growth buyout market, recurring revenue mix, not sector label alone, shapes sector preference, since two companies in entirely different sectors can attract remarkably similar growth buyout interest once their recurring revenue mix and EBITDA margin are compared.
This page describes twenty-two sector categories across four sector groupings strictly as market segments.
It provides no investment advice, solicitation to invest or performance guarantee of any kind.
A vertical software company and a specialty healthcare provider can carry a remarkably similar recurring revenue mix even though they sit in entirely different sector groupings.
That revenue-driven pattern is why funds experienced in this market organise sector coverage around recurring revenue mix as much as around any single sector category.
For deal teams, identifying a target's specific recurring revenue mix is a more reliable starting point than sector classification alone.
For funds, sector expertise across the widest possible range captures deal flow that a purely sector-focused origination approach would miss.
This pattern is most visible where the same fund evaluates multiple sector groupings from a single deal team, since recurring revenue mix rather than sector label often determines which target receives priority attention.
Funds that organise origination around recurring revenue mix first, rather than sector label alone, generally report broader deal flow when expanding into adjacent sector groupings.
This principle extends to value creation lever selection as well, since a target's recurring revenue mix often determines which lever applies more directly than sector classification alone.
SaaS, vertical software and enterprise software form three of the eight technology categories tracked in this report.
All three are named here as market categories, and this page states nothing about the technical performance of any software product.
SaaS and vertical software together account for a leading share of the technology sector focus category in this report, reflecting their established recurring revenue characteristics.
Vertical software is generally specified for a single industry's workflow, distinct from the broader horizontal positioning typical of enterprise software.
This grouping as a whole spans the widest range of investment strategies of any technology category tracked in this report.
For funds, this grouping continues to anchor the largest share of technology sector deal flow despite growth concentrating in cybersecurity and data and analytics elsewhere in the segmentation.
Both categories draw interest across the full range of enterprise value bands tracked in this report, though the 50 million euro to 250 million euro bands remain the most active pairing for each.
This grouping's breadth directly reflects the scale of Europe's established software buyer base across the United Kingdom, Nordic region and DACH Expansion Markets.
Enterprise software companies typically carry a longer sales cycle than vertical software companies, reflecting the broader stakeholder base a horizontal product must satisfy.
Commercially, this grouping generally involves the most standardised due diligence process of the eight technology categories tracked in this report, given how established SaaS metrics have become across mid-market Europe.
Cybersecurity, data and analytics, cloud infrastructure and FinTech infrastructure complete the technology sector grouping tracked in this report.
These categories connect to the EBITDA profile each sector typically carries.
All four are named here as market categories, and this page states nothing about the technical effectiveness of any security, data or infrastructure product.
Cybersecurity forms a fast-growing technology category in this report, closely tied to digital transformation demand identified among this report's buying triggers.
FinTech infrastructure is generally associated with the financial technology buyer industry identified elsewhere in this report's buyer intelligence, distinct from the broader digital infrastructure category.
Commercially, this grouping requires funds with established multi-sector technical diligence capability, narrowing the field of qualified investors relative to single-category specialists.
For funds, cybersecurity and cloud infrastructure capability is a meaningful differentiator given the pace of digital transformation demand identified among this report's buying triggers.
Data and analytics companies generally carry a higher recurring revenue mix than cloud infrastructure companies, reflecting the subscription-based commercial model most common in this category.
This grouping's activity concentrates most heavily in the United Kingdom and Nordic region, where established digital infrastructure investment has widened the pool of qualifying targets.
For funds, capability across cybersecurity, data and analytics, cloud infrastructure and FinTech infrastructure widens addressable scope across the majority of digital transformation-driven deal flow this report tracks.
|
TECHNOLOGY WATCH Cybersecurity and data and analytics targets are increasingly evaluated alongside cloud infrastructure capability as a single technical diligence exercise, rather than as separate specialist categories, reflecting how tightly these three categories now operate together inside a typical enterprise software stack. |
Healthcare IT, medical technology, diagnostics and specialty healthcare providers form four of the six healthcare categories tracked in this report.
All four are named here as market categories, and this page states nothing about the clinical effectiveness or health outcome of any healthcare product or service.
Healthcare, spanning healthcare IT and medical technology, forms a fast-growing sector focus category in this report, reflecting rising investor demand for recurring revenue business models identified among this report's market drivers.
Diagnostics generally carries a different regulatory and reimbursement profile than healthcare IT, reflecting the more clinical positioning typical of this category.
Specialty healthcare providers generally specify a longer due diligence period than healthcare IT companies, reflecting the additional regulatory and reimbursement review this category typically requires.
This grouping as a whole spans the widest range of EBITDA profiles of any healthcare category tracked in this report.
For funds, healthcare technology gaps identified in this report's competitive mapping represent an underserved opportunity distinct from the more heavily contested SaaS and enterprise software categories.
Buyers evaluating this grouping generally place a higher premium on regulatory and reimbursement due diligence than on growth rate alone, given the compliance-driven nature of healthcare specification.
For funds, healthcare IT capability is a meaningful differentiator given its position tied to this report's fast-growing sector focus category.
Commercially, this grouping requires funds with established healthcare regulatory diligence experience, narrowing the field of qualified investors relative to generalist technology specialists.
Contract research services and pharma services complete the healthcare sector grouping tracked in this report.
Both are named here as market categories, and this page states nothing about the clinical or regulatory outcome either service category delivers.
Contract research services generally carries the longest sales cycle of the six healthcare categories tracked in this report, reflecting the multi-year client relationships typical of this category.
Pharma services companies generally specify a broader range of investment strategies than contract research services, spanning growth equity through platform acquisition depending on the specific service line involved.
Commercially, this grouping requires funds with established life sciences sector expertise, narrowing the field of qualified investors considerably relative to generalist healthcare specialists.
For funds, contract research services and pharma services capability is a differentiator for targets with life sciences-specific buyer relationships.
Buyers in this grouping generally place a higher premium on client concentration and contract renewal history than on headline revenue growth alone, given the relationship-driven nature of this category.
This category's fast-growing position within pharma services reflects rising outsourcing activity among pharmaceutical companies seeking to focus internal resources on core drug development.
For funds, engaging a target with proven multi-year client renewal history early generally reduces both commercial and diligence risk on contract research services transactions.
Commercially, contract research services and pharma services together represent a smaller but distinct share of overall healthcare sector deal flow than healthcare IT and medical technology.
Pharma services companies serving multiple pharmaceutical clients simultaneously generally command a premium over single-client service providers, reflecting the lower customer concentration risk a diversified client base carries into diligence.
Business services and industrial technology complete the sector focus dimension tracked in this report.
These sector groupings connect to the value creation levers each sector favours.
Both are named here as market categories, and this page states nothing about the operational performance of any company within either grouping.
Business services spans outsourced services, compliance services, professional services and information services, generally carrying a more fragmented competitive landscape than the technology grouping covered elsewhere on this page.
Industrial technology spans automation, industry 4.0, digital manufacturing and engineering software, generally paired with the operational excellence and digital transformation levers covered on this report's value creation page.
Commercially, business services companies frequently pursue sector consolidation strategy given the fragmented competitive landscape typical of this grouping.
For funds, industrial technology capability is a meaningful differentiator given the pace of digital manufacturing and Industry 4.0 adoption identified among this report's market drivers.
Buyers evaluating business services targets generally weigh client concentration and contract renewal rate as closely as headline growth, given the relationship-dependent nature of this category.
Industrial technology targets generally carry a longer sales cycle than business services targets, reflecting the more complex, multi-stakeholder procurement process typical of industrial buyers.
For funds, capability across both business services and industrial technology widens addressable scope across the two sector groupings this report tracks least contested by generalist technology-focused investors.
Compliance services and information services within business services generally attract a different buyer profile than outsourced services, given the more regulatory-driven demand these two categories serve relative to a purely cost-driven outsourcing decision.
For funds, engineering software targets within industrial technology increasingly carry a recurring revenue mix closer to enterprise software than to traditional industrial equipment, narrowing the gap between these two sector groupings this page describes as historically distinct.
SaaS and vertical software together account for a leading share of technology sector deal flow, with cybersecurity and data and analytics forming a fast-growing category tied to digital transformation demand.
Yes. Healthcare forms a fast-growing sector focus category in this report, spanning healthcare IT, medical technology, diagnostics, contract research services, pharma services and specialty healthcare providers.
A technology category tracked in this report, generally specified for a single industry's workflow, distinct from the broader horizontal positioning typical of enterprise software.
Because two companies in entirely different sectors can attract remarkably similar growth buyout interest once their recurring revenue mix and EBITDA margin are compared.